Prothena | PRTA - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Akebia Therapeutics USD 184.84M 18.4M 2025-12
ALKERMES USD 351.55M 37.02M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Exelixis USD 482.49M 106.19M 2025-12
Immunic USD 15.48M 19.65M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
MacroGenics USD 57.22M 22.91M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Prothena USD 307.53M 23.31M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Ultragenyx Pharmaceutical USD 421M 218.49M 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Xoma USD 143.9M 7.68M 2024-06